Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors.
Narlı Özdemir Z, Şahin U, Dalva K, Baltacı MA, Uslu A, Öztürk C, Cengiz Seval G, Toprak SK, Kurt Yüksel M, Topçuoğlu P, Arslan Ö, Özcan M, Beksaç M, İlhan O, Gürman G, Civriz Bozdağ S.
Narlı Özdemir Z, et al.
Turk J Haematol. 2021 Jun 1;38(2):111-118. doi: 10.4274/tjh.galenos.2020.2020.0157. Epub 2020 Oct 28.
Turk J Haematol. 2021.
PMID: 33112099
Free PMC article.